ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
123.48
+1.81 (1.49%)
At close: Oct 24, 2025, 4:00 PM EDT
121.01
-2.47 (-2.00%)
After-hours: Oct 24, 2025, 5:28 PM EDT
ICU Medical Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$179.40
Upside
+45.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Buy Maintains $191 → $173 | Buy | Maintains | $191 → $173 | +40.10% | Oct 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $145 → $153 | Buy | Maintains | $145 → $153 | +23.91% | Sep 10, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $145 | Buy | Initiates | $145 | +17.43% | Aug 15, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $187 → $180 | Strong Buy | Maintains | $187 → $180 | +45.77% | Aug 8, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $197 → $187 | Strong Buy | Maintains | $197 → $187 | +51.44% | May 9, 2025 |
| Keybanc | Keybanc | Buy Maintains $209 → $191 | Buy | Maintains | $209 → $191 | +54.68% | Apr 21, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 8, 2025 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $200 | Hold → Strong Buy | Upgrades | $200 | +61.97% | Dec 11, 2024 |
| Keybanc | Keybanc | Buy Maintains $198 → $209 | Buy | Maintains | $198 → $209 | +69.26% | Nov 13, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 13, 2024 |
| Keybanc | Keybanc | Buy Maintains $147 → $198 | Buy | Maintains | $147 → $198 | +60.35% | Oct 15, 2024 |
| Jefferies | Jefferies | Hold Initiates $183 | Hold | Initiates | $183 | +48.20% | Oct 14, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 10, 2024 |
| Raymond James | Raymond James | Buy Maintains $158 → $190 | Buy | Maintains | $158 → $190 | +53.87% | Sep 12, 2024 |
| Keybanc | Keybanc | Buy Maintains $136 → $147 | Buy | Maintains | $136 → $147 | +19.05% | Aug 8, 2024 |
| Raymond James | Raymond James | Buy Maintains $135 → $158 | Buy | Maintains | $135 → $158 | +27.96% | Aug 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.